Progress in Medicinal Chemistry
- 1 Edición, Volumen 42 - 15 de abril de 2004
- Última edición
- Autor: F.D. King
- Idioma: Inglés
This volume includes information on recent advances in five important areas: an account of inhibitors of the caspase family of proteolytic enzymes that represent a new class of an… Leer más
Descripción
Descripción
This volume includes information on recent advances in five important areas: an account of inhibitors of the caspase family of proteolytic enzymes that represent a new class of anti-inflammatory and antiapoptotic agents of potential value in rheumatoid arthritis; and a survey of semi-synthetic and totally synthetic antibiotics and anti-HIV agents and their sites of interaction; the development of inhibitors of the intracellular enzyme acyl-CoA: cholesterol O-acyltransferase (ACAT) for the treatment of hypercholesterolemia; a description of recent progress in growth hormone secretagogues, with the focus on strategies to improve oral bioavailability and duration of action; and information on inhibition of the proteolytic enzyme, hepatitis C protease N-3(NS3), (required for vital replication) as one of the most attractive targets for HCV infections.
Detalles del producto
Detalles del producto
- Edición: 1
- Última edición
- Volumen: 42
- Publicado: 15 de abril de 2004
- Idioma: Inglés
Sobre el autor
Sobre el autor
FK